Foresite Capital Management IV as of March 31, 2018
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 18 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed (INSM) | 16.8 | $41M | 1.8M | 22.52 | |
| Ascendis Pharma A S (ASND) | 12.9 | $31M | 475k | 65.40 | |
| Cymabay Therapeutics | 11.4 | $27M | 2.1M | 12.99 | |
| Biohaven Pharmaceutical Holding | 9.1 | $22M | 851k | 25.76 | |
| Myokardia | 7.9 | $19M | 392k | 48.80 | |
| Immunomedics | 6.5 | $16M | 1.1M | 14.61 | |
| Uniqure Nv (QURE) | 5.5 | $13M | 560k | 23.50 | |
| Alder Biopharmaceuticals | 4.4 | $11M | 831k | 12.70 | |
| Arcus Biosciences Incorporated (RCUS) | 4.2 | $10M | 650k | 15.44 | |
| Optinose (OPTN) | 4.0 | $9.7M | 484k | 20.02 | |
| Alder Biopharmaceuticals Inc put | 3.3 | $7.9M | 450k | 17.56 | |
| Aclaris Therapeutics (ACRS) | 3.1 | $7.5M | 430k | 17.52 | |
| Arbutus Biopharma (ABUS) | 3.1 | $7.4M | 1.5M | 5.00 | |
| Insmed | 2.8 | $6.8M | 300k | 22.67 | |
| Myokardia Inc put | 2.0 | $4.9M | 100k | 49.00 | |
| Rhythm Pharmaceuticals (RYTM) | 1.6 | $4.0M | 200k | 19.90 | |
| Ra Pharmaceuticals | 1.0 | $2.4M | 450k | 5.31 | |
| Solid Biosciences | 0.4 | $1.1M | 140k | 7.50 |
